Recombinant Human Antithrombin III Restores Heparin Responsiveness and Decreases Activation of Coagulation in Heparin-Resistant Patients During Cardiopulmonary Bypass
We sought to evaluate the efficacy of recombinant human antithrombin III for restoration of heparin responsiveness in heparin-resistant patients scheduled for cardiac surgery.
1 min read